The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma
Author
Muzaffar, Mahvish; Navaid, Musharraf; Naqash, Abdul Rafeh
Date
2022
Citation:
APA:
Muzaffar, Mahvish, & Navaid, Musharraf, & Naqash, Abdul Rafeh. (January 2022).
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/11729
MLA:
Muzaffar, Mahvish, and Navaid, Musharraf, and Naqash, Abdul Rafeh.
"The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma". .
. (),
January 2022.
April 28, 2024.
http://hdl.handle.net/10342/11729.
Chicago:
Muzaffar, Mahvish and Navaid, Musharraf and Naqash, Abdul Rafeh,
"The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma," , no.
(January 2022),
http://hdl.handle.net/10342/11729 (accessed
April 28, 2024).
AMA:
Muzaffar, Mahvish, Navaid, Musharraf, Naqash, Abdul Rafeh.
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. .
January 2022;
():
.
http://hdl.handle.net/10342/11729. Accessed
April 28, 2024.
Collections